Diagnosis and management of Parkinson’s disease dementia and dementia with Lewy bodies: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology

ABSTRACT Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) represent the second most common type of degenerative dementia in patients aged 65 years and older, leading to progressive cognitive dysfunction and impaired quality of life. This study aims to provide a consensus based on a systematic Brazilian literature review and a comprehensive international review concerning PDD and DLB. Moreover, we sought to report on and give recommendations about the best diagnostic approaches focusing on primary and secondary care. Based on the available data, we recommend clinicians to apply at least one brief global cognitive instrument to assess PDD, such as the Mini-Mental State Examination and preferably the Montreal Cognitive Assessment and the Addenbrooke’s Cognitive Examination-Revised. Validated instruments to accurately assess functional abilities in Brazilian PD patients are still incipient. Further studies should focus on biomarkers with Brazilian cohorts.

[1]  P. Bertolucci,et al.  Correlates of neuropsychiatric and motor tests with language assessment in patients with Lewy body dementia , 2020, Archives of Clinical Psychiatry (São Paulo).

[2]  Alan J. Thomas,et al.  Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies , 2020, Alzheimer's Research & Therapy.

[3]  M. H. Chagas,et al.  Validation of the Brazilian Portuguese version of the Rapid Eye Movement Sleep Behavior Disorder Screening Questionnaire (RBDSQ-BR) , 2020, Arquivos de Neuro-Psiquiatria.

[4]  P. Bertolucci,et al.  Neuropsychiatric feature profiles of patients with Lewy body dementia , 2020, Clinical Neurology and Neurosurgery.

[5]  Alan J. Thomas,et al.  Research criteria for the diagnosis of prodromal dementia with Lewy bodies , 2020, Neurology.

[6]  V. Tumas,et al.  Direct and indirect assessment of functional abilities in patients with Parkinson’s disease transitioning to dementia , 2020, Dementia & neuropsychologia.

[7]  R. Nisihara,et al.  Prevalence of dementia in patients seen at a private hospital in the Southern Region of Brazil , 2019, Einstein.

[8]  K. J. Almeida,et al.  Cut-off points of the Portuguese version of the Montreal Cognitive Assessment for cognitive evaluation in Parkinson’s disease , 2019, Dementia & neuropsychologia.

[9]  M. H. Chagas,et al.  Global cognitive performance is associated with sleep efficiency measured by polysomnography in patients with Parkinson's disease , 2019, Psychiatry and clinical neurosciences.

[10]  P. Caramelli,et al.  Parkinsonism in a population-based study of individuals aged 75+ years: The Pietà study. , 2018, Parkinsonism & related disorders.

[11]  H. Teive,et al.  Association between olfactory loss and cognitive deficits in Parkinson's disease , 2018, Clinical Neurology and Neurosurgery.

[12]  F Nobili,et al.  European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus , 2018, European journal of neurology.

[13]  C. Suemoto,et al.  Normative data for the Montreal Cognitive Assessment (MoCA) and the Memory Index Score (MoCA‐MIS) in Brazil: Adjusting the nonlinear effects of education with fractional polynomials , 2018, International journal of geriatric psychiatry.

[14]  C. Camargo,et al.  Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease? , 2017, Arquivos de Neuro-Psiquiatria.

[15]  M. Leite,et al.  Low Sensitivity of the Mini-Mental State Examination for Cognitive Assessment of Brazilian Patients With Parkinson Disease , 2017, Journal of geriatric psychiatry and neurology.

[16]  E. Barbosa,et al.  Modified Pfeffer Questionnaire for Functional Assessment in Parkinson Disease , 2017, Journal of geriatric psychiatry and neurology.

[17]  Alan J. Thomas,et al.  Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.

[18]  M. Yassuda,et al.  Addenbrooke's cognitive examination-revised: normative and accuracy data for seniors with heterogeneous educational level in Brazil , 2017, International Psychogeriatrics.

[19]  L. Grinberg,et al.  Neuropathological diagnoses and clinical correlates in older adults in Brazil: A cross-sectional study , 2017, PLoS medicine.

[20]  Annelise Ayres,et al.  Comparison Trail Making Test Between Individuals With Parkinson’s Disease and Health Controls: Suggestions of Cutoff Point , 2017 .

[21]  Annelise Ayres,et al.  The impact of cognitive performance on quality of life in individuals with Parkinson's disease , 2016, Dementia & neuropsychologia.

[22]  A. Hilbig,et al.  Neuropsychological profile of Parkinson's disease patients selected for deep brain stimulation surgery , 2016, Dementia & neuropsychologia.

[23]  C. Camargo,et al.  Comparison of the use of screening tools for evaluating cognitive impairment in patients with Parkinson's disease , 2016, Dementia & neuropsychologia.

[24]  I. Mata,et al.  Some aspects of the validity of the Montreal Cognitive Assessment (MoCA) for evaluating cognitive impairment in Brazilian patients with Parkinson's disease , 2016, Dementia & neuropsychologia.

[25]  V. Tumas,et al.  The interlocking finger test in patients with Parkinson’s disease and healthy subjects , 2016, Journal of Clinical Neuroscience.

[26]  I. Mata,et al.  Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised. , 2015, Arquivos de neuro-psiquiatria.

[27]  B. Boeve,et al.  Lewy body dementias , 2015, The Lancet.

[28]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[29]  V. Tumas,et al.  An analysis of the cognitive items of the movement disorders society checklist for the diagnosis of dementia in patients with Parkinson's disease. , 2015, Parkinsonism & related disorders.

[30]  S. M. C. Marin,et al.  Contrasts Between Patients With Lewy Body Dementia Syndromes and APOE-&egr;3/&egr;3 Patients With Late-onset Alzheimer Disease Dementia , 2015, The neurologist.

[31]  T. Asada,et al.  Diagnostic Accuracy of 123I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study , 2015, PloS one.

[32]  C. Mesquita,et al.  Cardiac 123I-MIBG uptake in de novo Brazilian patients with Parkinson's disease without clinically defined dysautonomia. , 2014, Arquivos de neuro-psiquiatria.

[33]  P. Martínez-Martín,et al.  Burden and health-related quality of life among caregivers of Brazilian Parkinson's disease patients. , 2013, Parkinsonism & related disorders.

[34]  G. Tedrus,et al.  Comparison of quantitative EEG between patients with Alzheimer’s disease and those with Parkinson’s disease dementia , 2013, Clinical Neurophysiology.

[35]  Virgínia Visconde Brasil,et al.  Qualidade de vida de quem cuida de portadores de demência com corpos de Lewy , 2013 .

[36]  S. Machado,et al.  Clinical diagnosis of 80 cases of dementia in a university hospital , 2013 .

[37]  P. C. Correa Ribeiro,et al.  Prevalence of Dementia in Elderly Clients of a Private Health Care Plan: A Study of the FIBRA-RJ, Brazil , 2013, Dementia and Geriatric Cognitive Disorders.

[38]  P. Caramelli,et al.  Normative Data for Healthy Middle-Aged and Elderly Performance on the Addenbrooke Cognitive Examination-Revised , 2012, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[39]  R. Barker,et al.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines , 2012, Movement disorders : official journal of the Movement Disorder Society.

[40]  R. Bazan,et al.  Metabolic syndrome and dementia associated with Parkinson's disease: impact of age and hypertension. , 2012, Arquivos de neuro-psiquiatria.

[41]  S. Brucki,et al.  Dementia in Parkinson's disease: a Brazilian sample. , 2011, Arquivos de neuro-psiquiatria.

[42]  L. Caixeta,et al.  Dementia and mild cognitive impairment in Parkinson's disease. , 2009, Arquivos de neuro-psiquiatria.

[43]  P. Caramelli,et al.  Depression Impairs Executive Functioning in Parkinson Disease Patients With Low Educational Level , 2009, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[44]  G. Tedrus,et al.  Dementia, Mild Cognitive Impairment and Quantitative EEG in Patients with Parkinson's Disease , 2009, Clinical EEG and neuroscience.

[45]  C. Bottino,et al.  Estimate of Dementia Prevalence in a Community Sample from São Paulo, Brazil , 2008, Dementia and Geriatric Cognitive Disorders.

[46]  V. Tumas,et al.  Visuospatial cognitive tests for the evaluation of patients with Parkinson's disease , 2008, Dementia & neuropsychologia.

[47]  V. Tumas,et al.  Executive cognitive tests for the evaluation of patients with Parkinson’s disease , 2008, Dementia & neuropsychologia.

[48]  E. Tolosa,et al.  Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force , 2007, Movement disorders : official journal of the Movement Disorder Society.

[49]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[50]  I. McKeith,et al.  Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study , 2007, The Lancet Neurology.

[51]  P. Caramelli,et al.  Parkinsonism and Parkinson's disease in the elderly: A community‐based survey in Brazil (the Bambuí study) , 2006, Movement disorders : official journal of the Movement Disorder Society.

[52]  Ricardo Nitrini,et al.  Prevalence of potentially reversible dementias in a dementia outpatient clinic of a tertiary university-affiliated hospital in Brazil. , 2003, Arquivos de neuro-psiquiatria.

[53]  R. Nitrini,et al.  Epidemiologic Survey of Dementia in a Community-Dwelling Brazilian Population , 2002, Alzheimer disease and associated disorders.

[54]  J. Cummings,et al.  Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease , 2001, International journal of geriatric psychiatry.

[55]  Nobuyuki Okamura,et al.  Glucose Hypometabolism and Neuropathological Correlates in Brains of Dementia with Lewy Bodies , 2000, Experimental Neurology.

[56]  J. Pereira,et al.  [Cognitive disorders in Parkinson disease. Electroencephalographic correlations]. , 1995, Arquivos de neuro-psiquiatria.

[57]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[58]  E. Barbosa,et al.  [Neuropsychological dysfunctions in Parkinson's disease: a study of 64 cases]. , 1987, Arquivos de neuro-psiquiatria.

[59]  P. Caramelli,et al.  MACHINE LEARNING-BASED ROUTINE LABORATORY VARIABLES SCREENING FOR ONE-YEAR COGNITIVE AND FUNCTIONAL DECLINE IN INDIVIDUALS AGED 75+ YEARS: THE PIETÀ STUDY , 2021, Dementia & Neuropsychologia.

[60]  C. Camargo,et al.  Patients with dementia syndrome in public and private services in southern Brazil , 2015, Dementia & neuropsychologia.

[61]  S. Brucki,et al.  Addenbrooke's Cognitive Examination-Revised is accurate for detecting dementia in Parkinson's disease patients with low educational level , 2014, Dementia & neuropsychologia.

[62]  P. R. D. de Bittencourt,et al.  [Digital EEG with brain mapping in Alzheimer's dementia and Parkinson's disease. A prospective controlled study]. , 1996, Arquivos de neuro-psiquiatria.